Literature DB >> 15176434

Overexpression of LIM kinase 1 renders resistance to apoptosis in PC12 cells by inhibition of caspase activation.

E Yang1, H Kim, J Lee, J S Shin, H Yoon, S J Kim, I H Choi.   

Abstract

LIM kinases (LIMKs) regulate actin polymerization by phosphorylating cofilin and are predominantly expressed in neural tissue. In this study, the effect of LIMK1 overexpression in PC12 cell apoptosis was investigated. PC12 cells overexpressing the wild-type LIMK1 were more resistant to serum-withdrawal-induced cell death and the level of caspase 3 activation in these cells was lower than in the control PC12 cells or than in the PC12 cells expressing a mutant LIMK1 lacking the kinase domain. The inhibition of JNK activation was observed in the PC12 cells overexpressing the wild-type LIMK1 after serum withdrawal. These results suggest that the LIMK1 might allow resistance to apoptosis in PC12 cells by inhibiting JNK activation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15176434     DOI: 10.1023/b:cemn.0000018615.84358.33

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  39 in total

1.  Inhibition of p38 kinase mimics survival signal-linked protection against apoptosis in rat cerebellar granule neurons.

Authors:  R Nath; K McGinnis; S Dutta; B Shivers; K K Wang
Journal:  Cell Mol Biol Lett       Date:  2001       Impact factor: 5.787

2.  Inhibitors of p38 mitogen-activated protein kinase promote neuronal survival in vitro.

Authors:  S Horstmann; P J Kahle; G D Borasio
Journal:  J Neurosci Res       Date:  1998-05-15       Impact factor: 4.164

3.  Manganese-induced rat pheochromocytoma (PC12) cell death is independent of caspase activation.

Authors:  J A Roth; L Feng; J Walowitz; R W Browne
Journal:  J Neurosci Res       Date:  2000-07-15       Impact factor: 4.164

4.  Activation of mitogen-activated protein kinase by H2O2. Role in cell survival following oxidant injury.

Authors:  K Z Guyton; Y Liu; M Gorospe; Q Xu; N J Holbrook
Journal:  J Biol Chem       Date:  1996-02-23       Impact factor: 5.157

Review 5.  The mitogen-activated protein kinase signal transduction pathway.

Authors:  R J Davis
Journal:  J Biol Chem       Date:  1993-07-15       Impact factor: 5.157

6.  JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain.

Authors:  B Dérijard; M Hibi; I H Wu; T Barrett; B Su; T Deng; M Karin; R J Davis
Journal:  Cell       Date:  1994-03-25       Impact factor: 41.582

7.  Involvement of p38 mitogen-activated protein kinase and apoptosis signal-regulating kinase-1 in nitric oxide-induced cell death in PC12 cells.

Authors:  O J Han; K H Joe; S W Kim; H S Lee; N S Kwon; K J Baek; H Y Yun
Journal:  Neurochem Res       Date:  2001-05       Impact factor: 3.996

8.  CD95 (APO-1/Fas) linkage to the actin cytoskeleton through ezrin in human T lymphocytes: a novel regulatory mechanism of the CD95 apoptotic pathway.

Authors:  S Parlato; A M Giammarioli; M Logozzi; F Lozupone; P Matarrese; F Luciani; M Falchi; W Malorni; S Fais
Journal:  EMBO J       Date:  2000-10-02       Impact factor: 11.598

9.  TRAIL/Apo2L activates c-Jun NH2-terminal kinase (JNK) via caspase-dependent and caspase-independent pathways.

Authors:  F Mühlenbeck; E Haas; R Schwenzer; G Schubert; M Grell; C Smith; P Scheurich; H Wajant
Journal:  J Biol Chem       Date:  1998-12-04       Impact factor: 5.157

10.  Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis.

Authors:  Z Xia; M Dickens; J Raingeaud; R J Davis; M E Greenberg
Journal:  Science       Date:  1995-11-24       Impact factor: 47.728

View more
  2 in total

Review 1.  Cofilin-mediated neurodegeneration in Alzheimer's disease and other amyloidopathies.

Authors:  Michael T Maloney; James R Bamburg
Journal:  Mol Neurobiol       Date:  2007-02       Impact factor: 5.590

Review 2.  The Role of ADF/Cofilin in Synaptic Physiology and Alzheimer's Disease.

Authors:  Youssif Ben Zablah; Neil Merovitch; Zhengping Jia
Journal:  Front Cell Dev Biol       Date:  2020-11-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.